Adults with obesity achieved greater long-term weight loss if they partook in a nutrition plan designed for rapid weight loss ...

Weight-loss injections continue to reshape conversations around obesity treatment and metabolic health. Men across different ...

Dr. Amrita Ghosh explains the difference between muscle loss and fat loss. And if you drop weight too fast, it can destroy ...

Many of the patients who tested the drug lost about 30 percent of their body weight — a loss comparable to the result of bariatric surgery ...

“Semaglutide is very effective for weight loss,” says Dr. Saunders. In fact, a 2021 phase 3 clinical trial found that 2.4 ...

In a clinical trial, the new weight-loss medication retatrutide led to "clinically meaningful weight reduction," with the ...

(RTTNews) - Eli Lilly and Co. (LLY) announced that Zepbound (tirzepatide) demonstrated a significantly greater weight reduction compared to Wegovy (semaglutide) in all comparisons conducted during the ...

The UAE has become the second country globally to approve the treatment, underscoring its leadership in adopting advanced ...

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs ...

Lilly’s weight loss pill gained approval in April 2026, around three months after Novo Nordisk gained the same accolade for oral Wegovy.

Eli Lilly and Company (NYSE: LLY), the maker of Zepbound (tirzepatide) and Foundayo (orforglipron), today announced positive topline results from TRIUMPH-1, a Phase 3 clinical trial evaluating the ...

A new study shows those who took retatrutide lost a whopping 28% of their body weight after 80 weeks, similar to weight loss ...